Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort, Dose-Ranging Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 21 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs EDP-1815 (Primary)
Indications Plaque psoriasis
Focus Therapeutic Use
Sponsors Evelo Biosciences

Most Recent Events

07 Sep 2022 According to an Evelo Biosciences media release, results from this trial were presented in a poster at the 2022 European Academy of Dermatology and Venereology (EADV) Congress.
07 Sep 2022 Results published in an Evelo Biosciences Media Release.
26 Mar 2022 Results presented in the Evelo Biosciences Media Release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com